簡介

本頁面提供了有關 Francis Patrick Ostronic 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Francis Patrick Ostronic已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:CYTH / Cyclo Therapeutics, Inc. Director 419,100
如何解讀這些圖表

以下圖表顯示了在Francis Patrick Ostronic進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 Francis Patrick Ostronic 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2025-03-03 2025-02-27 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
A - Award 70,329 419,100 20.16
2024-06-05 2024-06-03 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
A - Award 10,743 348,771 3.18
2024-02-15 2024-02-13 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
A - Award 8,703 338,028 2.64
2023-11-30 2023-11-28 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
A - Award 10,262 329,325 3.22
2023-10-23 2023-10-20 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
X - Other 59,881 308,952 24.04 0.71 42,516 219,356
2023-08-22 2023-08-18 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
A - Award 10,111 259,182 4.06
2023-05-18 2023-05-17 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
A - Award 26,700 249,071 12.01
2023-04-24 2023-04-20 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 59,881 222,371 36.85 0.71 42,516 157,883
2022-11-09 2022-11-08 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
A - Award 11,803 162,490 7.83
2022-09-22 2022-09-21 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 5,000 150,687 3.43 1.76 8,800 265,209
2022-08-04 2022-08-02 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
A - Award 7,162 145,687 5.17
2022-05-23 2022-05-20 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 4,988 138,525 3.74 2.04 10,175 282,577
2022-05-23 2022-05-20 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 12 133,537 0.01 2.00 24 267,074
2022-05-04 2022-05-03 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
A - Award 5,249 133,525 4.09
2022-05-04 2022-05-03 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
A - Award 5,249 133,525 4.09
2022-04-07 2022-04-06 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
A - Award 5,000 128,276 4.06 2.90 14,500 372,000
2022-02-04 2022-02-04 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
A - Award 5,000 123,276 4.23 3.30 16,500 406,811
2022-02-01 2022-01-28 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
A - Award 5,065 118,276 4.47
2022-01-24 2022-01-24 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 2,000 113,211 1.80 3.75 7,500 424,541
2022-01-19 2022-01-19 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 1,132 111,211 1.03 4.00 4,528 444,844
2022-01-18 2022-01-14 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 1,731 110,079 1.60 4.00 6,924 440,316
2022-01-14 2022-01-14 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 2,137 108,348 2.01 4.00 8,548 433,392
2021-12-15 2021-12-15 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 3,000 106,211 2.91 3.90 11,700 414,223
2021-12-10 2021-12-10 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 5,000 103,211 5.09 4.40 22,000 454,128
2021-12-06 2021-12-03 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 864 98,211 0.89 4.75 4,104 466,502
2021-12-02 2021-12-02 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 4,136 97,347 4.44 4.75 19,646 462,398
2021-12-01 2021-12-01 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 5,000 93,211 5.67 5.00 25,000 466,055
2021-11-19 2021-11-19 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 10,000 88,211 12.79 5.25 52,500 463,108
2021-11-19 2021-11-19 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 652 78,211 0.84 5.22 3,403 408,261
2021-11-01 2021-10-29 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 1,000 77,559 1.31 5.90 5,900 457,598
2021-08-30 2021-08-27 4 CYTH Cyclo Therapeutics, Inc.
Stock Option (Right to buy)
A - Award 6,700 6,700
2021-06-02 2021-05-21 4 CYTH Cyclo Therapeutics, Inc.
Warrant to Purchase Common Stock
P - Purchase 100 100 3.25 325 325
2021-04-16 2021-04-16 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 5,000 76,559 6.99 6.30 31,500 482,322
2021-04-16 2021-04-16 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 5,000 71,559 7.51 6.75 33,750 483,023
2021-04-12 2021-04-12 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 5,000 66,559 8.12 7.00 35,000 465,913
2021-03-30 2021-03-29 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 2,000 61,559 3.36 7.60 15,200 467,848
2021-03-30 2021-03-29 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 1,000 59,559 1.71 7.40 7,400 440,737
2020-12-17 2020-12-17 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 19,800 58,559 51.08 4.70 93,060 275,227
2020-12-17 2020-12-17 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 200 38,759 0.52 4.69 938 181,780
2020-12-17 2020-12-17 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 5,000 38,559 14.90 4.60 23,000 177,371
2020-12-17 2020-12-17 4 CYTH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 5,000 33,559 17.51 4.55 22,750 152,693
2020-08-28 2020-08-27 4 CTDH Cyclo Therapeutics, Inc.
Warrant to Purchase Common Stock
P - Purchase 500,000 500,000
2020-08-28 2020-08-27 4 CTDH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 500,000 2,855,890 21.22
2020-04-27 2020-04-24 4 CTDH Cyclo Therapeutics, Inc.
Common Stock
P - Purchase 1,000,000 2,355,890 73.75 0.10 100,000 235,589
2019-09-18 2019-09-16 4 CTDH CTD HOLDINGS INC
Common Stock
P - Purchase 100,000 1,355,890 7.96 0.19 19,000 257,619
2019-09-13 2019-09-11 4 CTDH CTD HOLDINGS INC
Common Stock
P - Purchase 1,000 1,255,890 0.08 0.18 180 226,060
2019-08-29 2019-08-28 4 CTDH CTD HOLDINGS INC
Common Stock
P - Purchase 6,131 1,254,890 0.49 0.20 1,226 250,978
2019-08-29 2019-08-27 4 CTDH CTD HOLDINGS INC
Common Stock
P - Purchase 16,200 1,248,759 1.31 0.20 3,240 249,752
2019-08-29 2019-08-26 4 CTDH CTD HOLDINGS INC
Common Stock
P - Purchase 17,500 1,232,559 1.44 0.20 3,500 246,512
2019-08-29 2019-08-22 4 CTDH CTD HOLDINGS INC
Common Stock
P - Purchase 10,169 1,215,059 0.84 0.20 2,034 243,012
2019-08-02 2019-08-01 4 CTDH CTD HOLDINGS INC
Common Stock
P - Purchase 7,000 1,204,890 0.58 0.22 1,540 265,076
2019-08-02 2019-08-01 4 CTDH CTD HOLDINGS INC
Common Stock
P - Purchase 93,000 1,197,890 8.42 0.23 21,390 275,515
2019-08-02 2019-08-01 4 CTDH CTD HOLDINGS INC
Common Stock
P - Purchase 100,000 1,104,890 9.95 0.24 24,000 265,174
2019-07-31 2019-07-31 4 CTDH CTD HOLDINGS INC
Common Stock
P - Purchase 100,000 1,004,890 11.05 0.25 25,000 251,222
2019-06-03 2019-05-31 4 CTDH CTD HOLDINGS INC
Warrant to Purchase Common Stock
P - Purchase 200,000 200,000
2019-06-03 2019-05-31 4 CTDH CTD HOLDINGS INC
Common Stock
P - Purchase 200,000 904,890 28.37
2018-12-26 2018-12-21 4 CTDH CTD HOLDINGS INC
Warrant to Purchase Common Stock
P - Purchase 38,462 38,462
2018-12-26 2018-12-21 4 CTDH CTD HOLDINGS INC
Common Stock
P - Purchase 38,462 704,890 5.77
2018-06-28 2018-05-23 4 CTDH CTD HOLDINGS INC
Series B Convertible Preferred Stock
C - Conversion -500 0 -100.00
2018-06-28 2018-05-23 4 CTDH CTD HOLDINGS INC
Common Stock
C - Conversion 200,000 666,428 42.88
2018-04-25 2018-04-23 4 CTDH CTD HOLDINGS INC
Warrant to Purchase Common Stock
P - Purchase 100,000 100,000
2018-04-25 2018-04-23 4 CTDH CTD HOLDINGS INC
Series B Convertible Preferred Stock
P - Purchase 250 500 100.00
2018-02-05 2018-02-01 4 CTDH CTD HOLDINGS INC
Common Stock
A - Award 20,000 466,428 4.48
2017-10-19 2017-10-18 4 CTDH CTD HOLDINGS INC
Warrant to Purchase Common Stock
P - Purchase 100,000 100,000
2017-10-19 2017-10-18 4 CTDH CTD HOLDINGS INC
Series B Convertible Preferred Stock
P - Purchase 250 250
2017-04-04 2017-03-31 4 CTDH CTD HOLDINGS INC
Common Stock
A - Award 20,000 446,428 4.69
2017-02-27 2017-02-23 4 CTDH CTD HOLDINGS INC
Warrant to Purchase Common Stock
P - Purchase 71,428 71,428
2017-02-27 2017-02-23 4 CTDH CTD HOLDINGS INC
Common Stock
P - Purchase 71,428 426,428 20.12
2016-07-26 2016-07-22 4 CTDH CTD HOLDINGS INC
Common Stock
A - Award 20,000 355,000 5.97
2016-06-08 2016-06-06 4 CTDH CTD HOLDINGS INC
Warrant to Purchase Common Stock
P - Purchase 200,000 200,000
2016-06-08 2016-06-06 4 CTDH CTD HOLDINGS INC
Common Stock
P - Purchase 200,000 335,000 148.15
2015-07-14 2015-07-10 4 CTDH CTD HOLDINGS INC
Common Stock
P - Purchase 100,000 135,000 285.71 0.50 50,000 67,500
2015-02-17 2014-11-07 4 CTDH CTD HOLDINGS INC
Common Stock
A - Award 20,000 35,000 133.33
2014-04-21 3 CTDH CTD HOLDINGS INC
Common Stock
30,000
2014-04-21 3 CTDH CTD HOLDINGS INC
Common Stock
30,000
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)